Predict your next investment

BioSapien company logo
HEALTHCARE | Biotechnology
biosapien.com

See what CB Insights has to offer

Total Raised

$1.8M

Investors Count

4

BioSapien Funding, BioSapien Valuation & BioSapien Revenue

6 Fundings

BioSapien's latest funding round was a Angel for $1.8M on December 15, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

12/15/2021

Angel

$1.8M

1

3/31/2021

Convertible Note - II

0

11/8/2020

Acquired

0

1/20/2020

Convertible Note

0

9/12/2019

Seed

0

Date

12/15/2021

3/31/2021

11/8/2020

1/20/2020

9/12/2019

Round

Angel

Convertible Note - II

Acquired

Convertible Note

Seed

Amount

$1.8M

Investors

Valuation

Revenue

Sources

1

0

0

0

0

BioSapien Investors

4 Investors

BioSapien has 4 investors. JPIN VCATS invested in BioSapien's Angel funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/15/2021

12/15/2021

1
Angel

Angel Investor (Group)

India

00/00/0000

00/00/0000

SOSV

Subscribe to see more

Venture Capital

New Jersey

00/00/0000

00/00/0000

Conduct Science

Subscribe to see more

Corporation

New York

00/00/0000

00/00/0000

ELabNYC

Subscribe to see more

Incubator/Accelerator

New York

First funding

12/15/2021

00/00/0000

00/00/0000

00/00/0000

Last Funding

12/15/2021

00/00/0000

00/00/0000

00/00/0000

Investor

SOSV

Conduct Science

ELabNYC

Rounds

1
Angel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Angel Investor (Group)

Venture Capital

Corporation

Incubator/Accelerator

Location

India

New Jersey

New York

New York

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.